Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment
Public ClinicalTrials.gov record NCT00004584. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety and Antiviral Efficacy of a Novel HIV-1 Protease Inhibitor, BMS-232632, in Combination Regimen(s) as Compared to a Reference Combination Regimen(s) in Antiretroviral-Experienced HIV-Infected Subjects
Study identification
- NCT ID
- NCT00004584
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Atazanavir Drug
- Ritonavir Drug
- Saquinavir Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 1999
- Primary completion
- Dec 31, 2001
- Completion
- Dec 31, 2001
- Last update posted
- May 3, 2011
1999 – 2002
United States locations
- U.S. sites
- 20
- U.S. states
- 12
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sorra Research Ctr / Med Forum | Birmingham | Alabama | 35203 | — |
| AIDS Healthcare Foundation | Los Angeles | California | 90027 | — |
| Robert Scott MD | Oakland | California | 94609 | — |
| Univ of California - Davis Med Ctr / CARES | Sacramento | California | 95817 | — |
| Avalar Medical Group | Tarzana | California | 91356 | — |
| Yale Univ School of Medicine / AIDS Program | New Haven | Connecticut | 06510 | — |
| Community Research Initiative of South Florida | Coral Gables | Florida | 33146 | — |
| HIV Clinical Research | Fort Lauderdale | Florida | 33316 | — |
| Infectious Disease Research Institute | Tampa | Florida | 33614 | — |
| Infectious Disease Specialists of Atlanta | Decatur | Georgia | 30033 | — |
| Louisiana State Univ Med Ctr / HIV Outpatient Clinic | New Orleans | Louisiana | 70112 | — |
| Albany Med College | Albany | New York | 12208 | — |
| St Vincents Hosp / Clinical Research Program | New York | New York | 10011 | — |
| Univ Hosps of Cleveland | Cleveland | Ohio | 44106 | — |
| The Research and Education Group | Portland | Oregon | 97210 | — |
| Julio Arroyo | West Columbia | South Carolina | 29169 | — |
| Vanderbilt Univ Med Ctr | Nashville | Tennessee | 37212 | — |
| Univ of Texas Southwestern Med Ctr of Dallas | Dallas | Texas | 75235 | — |
| Texas Tech Health Sciences Ctr | El Paso | Texas | 79905 | — |
| Houston Clinical Research Network / Div of Montrose Clinic | Houston | Texas | 77006 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00004584, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 3, 2011 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00004584 live on ClinicalTrials.gov.